Jennifer Keiser

1 in Phase 3

Quick facts

Phase 3 pipeline

Phase 2 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Jennifer Keiser

What is Jennifer Keiser's pipeline?

Jennifer Keiser has 1 drugs in Phase 3, 1 in Phase 2, 0 in Phase 1. Late-stage candidates include Albendazole 400 mg.

Related